Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

273 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Implications and hidden toxicity of cardiometabolic syndrome and early-stage heart failure in carfilzomib-induced cardiotoxicity.
Efentakis P, Varela A, Lamprou S, Papanagnou ED, Chatzistefanou M, Christodoulou A, Davos CH, Gavriatopoulou M, Trougakos I, Dimopoulos MA, Terpos E, Andreadou I. Efentakis P, et al. Among authors: gavriatopoulou m. Br J Pharmacol. 2024 Apr 28. doi: 10.1111/bph.16391. Online ahead of print. Br J Pharmacol. 2024. PMID: 38679957
Characteristics and Outcomes of Patients With Relapsed/Refractory Multiple Myeloma After Exposure to Lenalidomide in First Line of Therapy: A Single Center Database Review in Greece.
Kastritis E, Ntanasis-Stathopoulos I, Theodorakakou F, Migkou M, Roussou M, Malandrakis P, Kanellias N, Eleutherakis-Papaiakovou E, Fotiou D, Spiliopoulou V, Gavriatopoulou M, Patel S, Majer I, Boukis C, Fetani A, Dimopoulos MA, Terpos E. Kastritis E, et al. Among authors: gavriatopoulou m. Clin Lymphoma Myeloma Leuk. 2024 Mar 19:S2152-2650(24)00110-1. doi: 10.1016/j.clml.2024.03.003. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38616479 Free article.
Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatin.
Efentakis P, Choustoulaki A, Kwiatkowski G, Varela A, Kostopoulos IV, Tsekenis G, Ntanasis-Stathopoulos I, Georgoulis A, Vorgias CE, Gakiopoulou H, Briasoulis A, Davos CH, Kostomitsopoulos N, Tsitsilonis O, Dimopoulos MA, Terpos E, Chłopicki S, Gavriatopoulou M, Andreadou I. Efentakis P, et al. Among authors: gavriatopoulou m. Basic Res Cardiol. 2024 Mar 23. doi: 10.1007/s00395-024-01046-0. Online ahead of print. Basic Res Cardiol. 2024. PMID: 38520533
Exploring the molecular biomarker utility of circCCT3 in multiple myeloma: A favorable prognostic indicator, particularly for R-ISS II patients.
Papatsirou M, Kontos CK, Ntanasis-Stathopoulos I, Malandrakis P, Sideris DC, Fotiou D, Liacos CI, Gavriatopoulou M, Kastritis E, Dimopoulos MA, Scorilas A, Terpos E. Papatsirou M, et al. Among authors: gavriatopoulou m. Hemasphere. 2024 Jan 26;8(1):e34. doi: 10.1002/hem3.34. eCollection 2024 Jan. Hemasphere. 2024. PMID: 38434522 Free PMC article.
A rare case of TEMPI syndrome (telangiectasias, erythrocytosis, monoclonal gammopathy and ascites) associated with IgM monoclonal gammopathy.
Asimakopoulou S, Malandrakis P, Kamiliou A, Gavriatopoulou M, Bafa K, Samaras V, Anastasopoulou A, Variami E, Lakiotaki E, Korkolopoulou P, Kastritis E, Dimopoulos MA, Cholongitas E. Asimakopoulou S, et al. Among authors: gavriatopoulou m. Leuk Lymphoma. 2024 Feb 28:1-3. doi: 10.1080/10428194.2024.2323084. Online ahead of print. Leuk Lymphoma. 2024. PMID: 38419349 No abstract available.
Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRFHisGTG results in patients' poor treatment outcome.
Soureas K, Papadimitriou MA, Malandrakis P, Papanota AM, Adamopoulos PG, Ntanasis-Stathopoulos I, Liacos CI, Gavriatopoulou M, Sideris DC, Kastritis E, Dimopoulos MA, Scorilas A, Terpos E, Avgeris M. Soureas K, et al. Among authors: gavriatopoulou m. Br J Haematol. 2024 May;204(5):1790-1800. doi: 10.1111/bjh.19332. Epub 2024 Feb 27. Br J Haematol. 2024. PMID: 38414235
Cardiovascular complications of ribociclib in breast cancer patients.
Fiste O, Mavrothalassitis E, Apostolidou K, Trika C, Liontos M, Koutsoukos K, Kaparelou M, Dimitrakakis C, Gavriatopoulou M, Dimopoulos MA, Zagouri F. Fiste O, et al. Among authors: gavriatopoulou m. Crit Rev Oncol Hematol. 2024 Apr;196:104296. doi: 10.1016/j.critrevonc.2024.104296. Epub 2024 Feb 22. Crit Rev Oncol Hematol. 2024. PMID: 38395242 Review.
Belantamab mafodotin, lenalidomide and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Part 1 results of a phase I/II study.
Terpos E, Gavriatopoulou M, Ntanasis-Stathopoulos I, Malandrakis P, Fotiou D, Migkou M, Theodorakakou F, Spiliopoulou V, Kostopoulos IV, Syrigou RE, Eleutherakis-Papaiakovou E, Gkolfinopoulos S, Tsitsilonis OE, Kastritis E, Dimopoulos MA. Terpos E, et al. Among authors: gavriatopoulou m. Haematologica. 2024 Feb 15. doi: 10.3324/haematol.2023.284347. Online ahead of print. Haematologica. 2024. PMID: 38356458 Free article.
273 results